HomeDTIL • NASDAQ
add
Precision BioSciences Inc
Nakaraang pagsara
$9.11
Sakop ng araw
$8.93 - $9.29
Sakop ng taon
$8.25 - $19.43
Market cap
65.47M USD
Average na Volume
47.52K
P/E ratio
44.80
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 49.90M | 152.15% |
Gastos sa pagpapatakbo | 25.75M | 12.37% |
Net na kita | 32.75M | 375.41% |
Net profit margin | 65.63 | 209.22% |
Kita sa bawat share | 4.67 | 255.67% |
EBITDA | 25.24M | 2,268.21% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 123.57M | -10.32% |
Kabuuang asset | 165.80M | -8.75% |
Kabuuang sagutin | 91.09M | -38.31% |
Kabuuang equity | 74.71M | — |
Natitirang share | 7.23M | — |
Presyo para makapag-book | 0.87 | — |
Return on assets | 34.44% | — |
Return on capital | 69.47% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 32.75M | 375.41% |
Cash mula sa mga operasyon | -14.87M | 29.64% |
Cash mula sa pag-invest | -28.00K | 97.35% |
Cash mula sa financing | 702.00K | -62.10% |
Net change in cash | -14.20M | 30.20% |
Malayang cash flow | 21.17M | 321.98% |
Tungkol
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
Itinatag
2006
Website
Mga Empleyado
110
